Drew Pardoll

37PUBLICATIONS
299CO-AUTHORS
Haematological tumoursBiomaterialsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jul 10, 2026
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.

|Apr 17, 2026
γδ T cell-stromal networks modulate matrix composition and vascularity in foreign body response.

|Mar 16, 2026
Lethal toxin-equipped effector cells for the potential treatment of cancer.

Alexander H Pearlman, Brian J Mog, Michael S Hwang

|Feb 12, 2026
Tissue Injury and Biomaterial Treatment Modulate Tumor Growth and Response to Immunotherapy.

Anna Ruta, Elise F Gray-Gaillard, Jordan A Garcia

|Jan 16, 2026
Regulatory T cells clonally expand and contribute to stromal cell function in fibrotic response to synthetic implants.

Joscelyn C Mejías, Kavita Krishnan, Anna Ruta

|Dec 22, 2025
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers.

Jiaxin Ge, Joshua Urban, Sarah R DiNapoli

Pageof 7

Frequent Collaborators

8 joint publications

Chetan Bettegowda

7 joint publications

Kellie N Smith

7 joint publications

Maximilian F Konig

7 joint publications

Suman Paul